PVALB

Parvalbumin

Score: 0.335 Price: $0.33 Low Druggability Status: active Wiki: PVALB
🧠 Neurodegeneration
HYPOTHESES
1
PAPERS
0
KG EDGES
24
DEBATES
1

3D Protein Structure

🧬 PVALB — PDB 4CPR Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

Druggability & Clinical Context

Druggability
Low
Score: 0.34
Clinical Stage
Phase II
Target Class
Signaling Protein
Safety
0.30
Druggability Analysis
Drug Development0.50
Structural Tractability0.70
Target Class0.50
Safety Profile0.30
Key Metrics
PDB Structures:
7
Known Drugs:
2
Approved:
1
In Clinical Trials:
1
Drug Pipeline (2 compounds)
1 Approved
Druggability Rationale: PVALB presents low druggability (0.30) as a calcium-binding signaling protein with no known direct druggable mechanism; however, indirect modulation is feasible as evidenced by approved GABA modulators (Diazepam) and phase 2 candidates that target PV+ interneurons through downstream pathways rather than PVALB itself. The low druggability score reflects the challenge of targeting a structural calcium-binding protein directly, though the existing clinical precedent suggests therapeutic benefit through functional modulation of PV+ neuron activity.
Mechanism: No known druggable mechanism
Drug Pipeline (2 compounds)
1 Approved
Known Drugs:
Diazepam (approved) — GABA modulator affecting PV+ interneurons
TPA023 (phase2) — Alpha2/3-selective GABA modulator
Structural Data:
PDB (7) ✓AlphaFold ✓Cryo-EM —
1RJV1RWY1S3P1XVJ2JWW+2 more
UniProt: P20472

🧬 3D Protein Structure

🧬 PVALB — PDB 4CPR Click to expand interactive 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll

Selectivity & Safety Considerations

Selectivity challenges arise from PVALB's widespread expression across fast-spiking interneurons and muscle tissue; direct targeting risks off-target effects on skeletal and cardiac muscle. Indirect approaches via GABA-A receptor modulation offer better selectivity for CNS-restricted PV+ interneurons, though achieving neuron-subtype specificity remains challenging.

3D Protein Structure

PDB: Open in RCSB AlphaFold model

Interactive 3D viewer powered by RCSB PDB / Mol*. Use mouse to rotate, scroll to zoom.

Clinical Trials (3)

Relevant trials from ClinicalTrials.gov

Active
0
Completed
3
Total Enrollment
174
By Phase
PHASE2: 1 · PHASE4: 1 · Unknown: 1
Clinical Efficacy of Diazepam After Whiplash Completed
PHASE4 NCT05041985 n=89
Whiplash Injuries, Whiplash Injury of Cervical Spine
Interventions: Diazepam Tablets
Sponsor: Edin Mešanović | Started: 2020-01-01
Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy Completed
PHASE2 NCT03179891 n=35
Epilepsy
Interventions: Diazepam Buccal Film 12.5 mg
Sponsor: Aquestive Therapeutics | Started: 2017-05-25
Fixed-schedule Benzodiazepine Dosing vs Based on a CIWA-Ar Alcohol Protocol in Alcohol Detoxification. Completed
Unknown NCT04777552 n=50
Alcoholdependence, CIWA-R, Benzodiazepines
Interventions: diazepam (or equivalence if other benzod
Sponsor: Universitair Ziekenhuis Brussel | Started: 2015-10

Linked Hypotheses (10)

Closed-loop optogenetic targeting PV interneurons to restore theta-gamma coupling and prevent amyloi0.952
Optogenetic restoration of hippocampal gamma oscillations via selective PV interneuron activation us0.865
Closed-loop focused ultrasound targeting EC-II PV interneurons to restore theta-gamma coupling and p0.863
Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhythmogenesis and block 0.849
Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymphatic0.827
Closed-loop transcranial focused ultrasound targeting CA1 PV interneurons with real-time gamma feedb0.797
Prefrontal sensory gating circuit restoration via PV interneuron enhancement0.775
Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via direct PV 0.773
Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and block tau propagation 0.764
Closed-loop focused ultrasound targeting CA1 PV interneurons to restore theta-gamma coupling and blo0.716

Linked Experiments (1)

Closed-loop tFUS Enhances Glymphatic Clearance and Restores CA1 PV Interneuron Gamma in APP/PS1 Mice0.765

Scoring Dimensions

Portfolio 0.33 (25%) Druggability 0.34 (20%) Evidence 0.35 (20%) Safety 0.30 (15%) Competitive 0.40 (10%) Connectivity 0.30 (10%) 0.335 composite

Knowledge Graph (20)

associated with (8)

CASP3PVALBPVALBTNFPVALBAPPPVALBBDNFPVALBDLG4
▸ Show 3 more
APPPVALBTNFPVALBDLG4PVALB

co discussed (5)

PVALBSIRT3PVALBPDGFRBPVALBSREBF2PVALBGFAPPVALBSLC16A1

expressed in (1)

PVALBAmygdala

interacts with (4)

FKBP5PVALBPVALBNR3C1NR3C1PVALBPVALBFKBP5

involved in (1)

PVALBThalamo-Amygdala Signaling

participates in (1)

PVALBPrefrontal inhibitory circuits

Debate History (1)

Should PVALB (Parvalbumin) be prioritized as a therapeutic target for neurodegen2026-04-26